Annals of Case Reports (ISSN: 2574-7754)

case report

Case Report: Relapsing Opioid Use Disorder in the Context of COVID-19

Sivan Shahar1*, Sean Lynch1, Lidia Klepacz1,2, Stephen J. Ferrando1,2

1Department of Psychiatry and Behavioral Sciences, New York Medical College, New York, USA

2Department of Psychiatry, Westchester Medical Center, New York, USA

*Corresponding author: Sivan Shahar, Department of Psychiatry and Behavioral Sciences, New York Medical College, 40 Sunshine Cottage Road Valhalla, New York, USA

Received Date: 13 November, 2020; Accepted Date: 18 November, 2020; Published Date: 23 November, 2020

Abstract

Background and Objectives: The COVID-19 pandemic has led to an increase in substance use and substance use disorder relapse, particularly opioid use and Opioid Use Disorder (OUD). We highlight an innovative approach in identifying and treating patients at risk.

Case Report: We present a patient with opioid use disorder, who was brought into the Emergency Department for an escalation in mood symptoms and self-injurious intent. She was initiated on Medication-Assisted Treatment (MAT) for opioid use disorder and responded favorably to treatment.

Discussion and Conclusions: This case demonstrates the effectiveness of MAT in the treatment of those with OUD. Additionally, it provides a framework for identifying risk factors to allow clinicians to stratify patients at risk to initiate and optimize treatment prior to relapse.

Scientific Significance: This case highlights the importance of MAT in the treatment of relapsing opioid use disorder, and highlights practical guidelines for clinicians to ensure the continued availability of treatment for patients with OUD during the COVID-19 pandemic.

Keywords

Addiction; COVID-19; Medication-Assisted Treatment; Opioid-Use Disorder; Recreational Drug Use


Copyright and Licensing: This is an Open Access Journal Article Published Under Attribution-Share Alike CC BY-SA: Creative Commons Attribution-Share Alike 4.0 International License. With this license readers can share, distribute, download, even commercially, as long as the original source is properly cited. Read More.